MorphoSys AG
MOR · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $3 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $0 | $0 |
| Enterprise Value | $3 | $2 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -53.4% | -7.4% | 20% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 86% | 75.4% | 76.3% | 85.5% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,115.8% | 88.5% | -79.8% | -80.3% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,143.7% | 81.7% | -187.5% | -139.1% |
| EPS Diluted | -2.07 | 0.31 | -0.87 | -0.54 |
| % Growth | -767.7% | 135.6% | -61.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |